Dear readers of, please forgive the disruption. needs about $36850 in 2023. In 2022 we received donations from third parties of about $ 13870. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2023 would be over after a few days. This donation request is displayed 18,000 times a week, but only 40 people donate. If you find useful, please take a minute and support with your donation. Thank you!

Since 01.06.2021 is supported by the non-profit ADxS e.V..

$16307 of $36850 - as of 2023-08-31
Header Image
Venlafaxine for ADHD


Venlafaxine for ADHD

Brand names of venlafaxine include: Trevilor (D), Efexor (CH), Efectin (A)

Venaflaxin came on the market in 1993 and is approved only for adults (18 years and older).1

Venlafaxine acts primarily at the serotonin level, secondarily at the norepinephrine level as a reuptake inhibitor (SSNRI = selective serotonin-norepinephrine reuptake inhibitor), and even less so at the dopamine level.1

Venlafaxine has only been tested in a few studies with a small number of subjects in relation to ADHD. The improvement in ADHD symptoms was very modest, while side effects were significant.2
We therefore advise against the use of venlafaxine in ADHD.

Regarding the entire group of serotonin reuptake inhibitors, there are concerns about their use in ADHD.
See Comments on serotonin reuptake inhibitors (SSRIs) in ADHD In the article Medications for ADHD - overview.

Diese Seite wurde am 13.03.2023 zuletzt aktualisiert.